USD 359.17
(-3.14%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 3.16 Billion USD | 34.22% |
2022 | 2.35 Billion USD | 18.25% |
2021 | 1.99 Billion USD | 24.7% |
2020 | 1.59 Billion USD | -23.24% |
2019 | 2.08 Billion USD | -41.37% |
2018 | 3.55 Billion USD | 248.33% |
2017 | 1.02 Billion USD | -38.07% |
2016 | 1.64 Billion USD | 14.45% |
2015 | 1.43 Billion USD | 179.42% |
2014 | 515 Million USD | -48.81% |
2013 | 1 Billion USD | -22.5% |
2012 | 1.29 Billion USD | -3.49% |
2011 | 1.34 Billion USD | 5.62% |
2010 | 1.27 Billion USD | 14.99% |
2009 | 1.1 Billion USD | -3.52% |
2008 | 1.14 Billion USD | 12.82% |
2007 | 1.01 Billion USD | 30.82% |
2006 | 777.7 Million USD | 15.18% |
2005 | 675.2 Million USD | 44.99% |
2004 | 465.7 Million USD | 2.69% |
2003 | 453.5 Million USD | 31.22% |
2002 | 345.6 Million USD | 29.44% |
2001 | 267 Million USD | 20.81% |
2000 | 221 Million USD | 1039.18% |
1999 | 19.4 Million USD | -51.01% |
1998 | 39.6 Million USD | -68.4% |
1997 | 125.3 Million USD | 19.9% |
1996 | 104.5 Million USD | 20.11% |
1995 | 87 Million USD | 20.17% |
1994 | 72.4 Million USD | 20.27% |
1993 | 60.2 Million USD | 26.21% |
1992 | 47.7 Million USD | 44.11% |
1991 | 33.1 Million USD | 40.25% |
1990 | 23.6 Million USD | 22.92% |
1989 | 19.2 Million USD | 20.75% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 788 Million USD | -31.06% |
2024 Q2 | 825 Million USD | 4.7% |
2024 Q3 | 834 Million USD | 1.09% |
2023 Q2 | 738 Million USD | 24.66% |
2023 Q1 | 592 Million USD | 5.15% |
2023 Q4 | 1.14 Billion USD | 65.17% |
2023 Q3 | 692 Million USD | -6.23% |
2023 FY | 3.16 Billion USD | 34.22% |
2022 Q2 | 656 Million USD | 103.1% |
2022 Q1 | 323 Million USD | -51.21% |
2022 FY | 2.35 Billion USD | 18.25% |
2022 Q3 | 816 Million USD | 24.39% |
2022 Q4 | 563 Million USD | -31.0% |
2021 Q3 | 438 Million USD | -26.01% |
2021 FY | 1.99 Billion USD | 24.7% |
2021 Q2 | 592 Million USD | 96.03% |
2021 Q1 | 302 Million USD | -46.83% |
2021 Q4 | 662 Million USD | 51.14% |
2020 FY | 1.59 Billion USD | -23.24% |
2020 Q2 | -83 Million USD | -116.84% |
2020 Q3 | 621 Million USD | 848.19% |
2020 Q4 | 568 Million USD | -8.53% |
2020 Q1 | 493 Million USD | -32.0% |
2019 FY | 2.08 Billion USD | -41.37% |
2019 Q1 | 412 Million USD | -80.08% |
2019 Q3 | 466 Million USD | -2.92% |
2019 Q2 | 480 Million USD | 16.5% |
2019 Q4 | 725 Million USD | 55.58% |
2018 Q2 | 452 Million USD | 2.03% |
2018 FY | 3.55 Billion USD | 248.33% |
2018 Q1 | 443 Million USD | 277.91% |
2018 Q3 | 590 Million USD | 30.53% |
2018 Q4 | 2.06 Billion USD | 250.51% |
2017 Q4 | -249 Million USD | -157.37% |
2017 FY | 1.02 Billion USD | -38.07% |
2017 Q2 | 391 Million USD | -11.94% |
2017 Q1 | 444 Million USD | -12.94% |
2017 Q3 | 434 Million USD | 11.0% |
2016 Q3 | 355 Million USD | -6.58% |
2016 Q4 | 510 Million USD | 43.66% |
2016 Q1 | 402 Million USD | -22.99% |
2016 FY | 1.64 Billion USD | 14.45% |
2016 Q2 | 380 Million USD | -5.47% |
2015 Q2 | 392 Million USD | 75.0% |
2015 Q1 | 224 Million USD | -13.85% |
2015 Q3 | 301 Million USD | -23.21% |
2015 Q4 | 522 Million USD | 73.42% |
2015 FY | 1.43 Billion USD | 179.42% |
2014 Q1 | 70 Million USD | -81.87% |
2014 Q2 | 215 Million USD | 207.14% |
2014 Q4 | 260 Million USD | 356.14% |
2014 Q3 | 57 Million USD | -73.49% |
2014 FY | 515 Million USD | -48.81% |
2013 Q3 | 103 Million USD | -51.64% |
2013 FY | 1 Billion USD | -22.5% |
2013 Q4 | 386 Million USD | 274.76% |
2013 Q1 | 304 Million USD | 12.59% |
2013 Q2 | 213 Million USD | -29.93% |
2012 Q3 | 353 Million USD | 8.62% |
2012 FY | 1.29 Billion USD | -3.49% |
2012 Q1 | 350 Million USD | -12.72% |
2012 Q2 | 325 Million USD | -7.14% |
2012 Q4 | 270 Million USD | -23.51% |
2011 Q1 | 307 Million USD | 4.07% |
2011 Q4 | 401 Million USD | 22.63% |
2011 Q3 | 327 Million USD | 5.48% |
2011 Q2 | 310 Million USD | 0.98% |
2011 FY | 1.34 Billion USD | 5.62% |
2010 Q2 | 319 Million USD | -0.84% |
2010 FY | 1.27 Billion USD | 14.99% |
2010 Q3 | 337 Million USD | 5.64% |
2010 Q4 | 295 Million USD | -12.46% |
2010 Q1 | 321.7 Million USD | 5.13% |
2009 FY | 1.1 Billion USD | -3.52% |
2009 Q2 | 291.3 Million USD | 3.63% |
2009 Q1 | 281.1 Million USD | 1.22% |
2009 Q4 | 306 Million USD | 33.62% |
2009 Q3 | 229 Million USD | -21.39% |
2008 Q4 | 277.7 Million USD | 1.42% |
2008 Q1 | 290.5 Million USD | 5.22% |
2008 FY | 1.14 Billion USD | 12.82% |
2008 Q3 | 273.8 Million USD | -10.46% |
2008 Q2 | 305.8 Million USD | 5.27% |
2007 Q4 | 276.1 Million USD | 20.73% |
2007 Q3 | 228.7 Million USD | -55.09% |
2007 Q2 | 509.2 Million USD | 110.59% |
2007 Q1 | 241.8 Million USD | 6.1% |
2007 FY | 1.01 Billion USD | 30.82% |
2006 FY | 777.7 Million USD | 15.18% |
2006 Q4 | 227.9 Million USD | 21.87% |
2006 Q3 | 187 Million USD | -12.58% |
2006 Q2 | 213.9 Million USD | 45.02% |
2006 Q1 | 147.5 Million USD | -20.57% |
2005 FY | 675.2 Million USD | 44.99% |
2005 Q3 | 120.7 Million USD | -32.11% |
2005 Q2 | 177.8 Million USD | 2.72% |
2005 Q1 | 173.1 Million USD | 6.39% |
2005 Q4 | 185.7 Million USD | 53.85% |
2004 FY | 465.7 Million USD | 2.69% |
2004 Q1 | 135.9 Million USD | 1.34% |
2004 Q3 | 14.4 Million USD | -90.57% |
2004 Q4 | 162.7 Million USD | 1029.86% |
2004 Q2 | 152.7 Million USD | 12.36% |
2003 Q1 | 104.1 Million USD | -1.89% |
2003 Q3 | 107.8 Million USD | 0.28% |
2003 Q2 | 107.5 Million USD | 3.27% |
2003 Q4 | 134.1 Million USD | 24.4% |
2003 FY | 453.5 Million USD | 31.22% |
2002 Q2 | 85.9 Million USD | 5.92% |
2002 Q3 | 72.5 Million USD | -15.6% |
2002 Q4 | 106.1 Million USD | 46.34% |
2002 FY | 345.6 Million USD | 29.44% |
2002 Q1 | 81.1 Million USD | 5.32% |
2001 Q3 | 60 Million USD | -8.68% |
2001 FY | 267 Million USD | 20.81% |
2001 Q1 | 64.1 Million USD | -3.61% |
2001 Q2 | 65.7 Million USD | 2.5% |
2001 Q4 | 77 Million USD | 28.33% |
2000 FY | 221 Million USD | 1039.18% |
2000 Q4 | 66.5 Million USD | 33.0% |
2000 Q3 | 50 Million USD | -5.12% |
2000 Q2 | 52.7 Million USD | 1.74% |
2000 Q1 | 51.8 Million USD | 18.26% |
1999 Q2 | -3.7 Million USD | 82.21% |
1999 Q3 | 100 Thousand USD | 102.7% |
1999 Q4 | 43.8 Million USD | 43700.0% |
1999 FY | 19.4 Million USD | -51.01% |
1999 Q1 | -20.8 Million USD | 68.67% |
1998 Q2 | 35.3 Million USD | -1.94% |
1998 Q4 | -66.4 Million USD | -290.8% |
1998 FY | 39.6 Million USD | -68.4% |
1998 Q1 | 36 Million USD | -2.44% |
1998 Q3 | 34.8 Million USD | -1.42% |
1997 Q3 | 29 Million USD | -1.36% |
1997 FY | 125.3 Million USD | 19.9% |
1997 Q1 | 30 Million USD | -2.6% |
1997 Q2 | 29.4 Million USD | -2.0% |
1997 Q4 | 36.9 Million USD | 27.24% |
1996 FY | 104.5 Million USD | 20.11% |
1996 Q4 | 30.8 Million USD | 27.27% |
1996 Q3 | 24.2 Million USD | -1.22% |
1996 Q2 | 24.5 Million USD | -2.0% |
1996 Q1 | 25 Million USD | -2.72% |
1995 Q3 | 20.1 Million USD | -1.47% |
1995 Q4 | 25.7 Million USD | 27.86% |
1995 Q1 | 20.8 Million USD | -2.35% |
1995 Q2 | 20.4 Million USD | -1.92% |
1995 FY | 87 Million USD | 20.17% |
1994 FY | 72.4 Million USD | 20.27% |
1994 Q2 | 17 Million USD | -1.73% |
1994 Q3 | 16.7 Million USD | -1.76% |
1994 Q4 | 21.3 Million USD | 27.54% |
1994 Q1 | 17.3 Million USD | -2.81% |
1993 Q3 | 14 Million USD | 0.0% |
1993 Q1 | 14.5 Million USD | -0.68% |
1993 Q2 | 14 Million USD | -3.45% |
1993 FY | 60.2 Million USD | 26.21% |
1993 Q4 | 17.8 Million USD | 27.14% |
1992 Q3 | 11 Million USD | -0.9% |
1992 Q2 | 11.1 Million USD | 0.91% |
1992 Q4 | 14.6 Million USD | 32.73% |
1992 Q1 | 11 Million USD | 5.77% |
1992 FY | 47.7 Million USD | 44.11% |
1991 Q4 | 10.4 Million USD | 38.67% |
1991 FY | 33.1 Million USD | 40.25% |
1991 Q3 | 7.5 Million USD | 1.35% |
1991 Q1 | 7.8 Million USD | 27.87% |
1991 Q2 | 7.4 Million USD | -5.13% |
1990 Q4 | 6.1 Million USD | 7.02% |
1990 Q3 | 5.7 Million USD | 3.64% |
1990 Q2 | 5.5 Million USD | -12.7% |
1990 FY | 23.6 Million USD | 22.92% |
1990 Q1 | 6.3 Million USD | 31.25% |
1989 FY | 19.2 Million USD | 20.75% |
1989 Q3 | 4.7 Million USD | 2.17% |
1989 Q2 | 4.6 Million USD | 0.0% |
1989 Q1 | - USD | 0.0% |
1989 Q4 | 4.8 Million USD | 2.13% |
Name | Net Income | Net Income Difference |
---|---|---|
Abbott Laboratories | 5.72 Billion USD | 44.697% |
Allurion Technologies Inc. | -82.3 Million USD | 3945.5% |
Artivion, Inc. | -30.69 Million USD | 10412.805% |
Avanos Medical, Inc. | -61.8 Million USD | 5221.359% |
Butterfly Network, Inc. | -133.69 Million USD | 2467.24% |
Butterfly Network, Inc. | -133.69 Million USD | 2467.24% |
Bio-Rad Laboratories, Inc. | -637.32 Million USD | 596.608% |
Boston Scientific Corporation | 1.59 Billion USD | -98.682% |
Perspective Therapeutics, Inc. | -14.67 Million USD | 21674.642% |
CONMED Corporation | 64.45 Million USD | -4810.098% |
Edwards Lifesciences Corporation | 1.4 Billion USD | -125.685% |
Paragon 28, Inc. | -47.84 Million USD | 6715.664% |
Glaukos Corporation | -134.66 Million USD | 2450.346% |
Globus Medical, Inc. | 122.87 Million USD | -2475.83% |
Inspire Medical Systems, Inc. | -21.15 Million USD | 15062.417% |
Integer Holdings Corporation | 90.65 Million USD | -3391.451% |
Medtronic plc | 3.67 Billion USD | 13.901% |
Nevro Corp. | -92.21 Million USD | 3532.271% |
Owlet, Inc. | -32.9 Million USD | 9719.768% |
Penumbra, Inc. | 90.95 Million USD | -3379.781% |
Vicarious Surgical Inc. | -71.07 Million USD | 4553.293% |
Smith & Nephew plc | 263 Million USD | -1103.422% |
Sonendo, Inc. | -60.91 Million USD | 5295.423% |
STERIS plc | 378.23 Million USD | -736.773% |
Vapotherm, Inc. | -58.19 Million USD | 5538.798% |
Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | -209.082% |